Here's why the Universal Biosensors (ASX:UBI) share price is soaring 10%

The Universal Biosensor Incorporated (ASX: UBI) share price is up 8% this morning after news of a deal with Deakin and Swinburn.

| More on:

Should you invest $1,000 in Betr Entertainment Ltd right now?

Before you buy Betr Entertainment Ltd shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Betr Entertainment Ltd wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Young doctor raising arms in air with hands in fists celebrating a new development

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Universal Biosensors Inc (ASX: UBI) shares are soaring today after the company shared news of deals with Deakin and Swinburn. At the time of writing, the Universal Biosensors share price is trading 9.68% higher at 68 cents. 

The deals will see the commercialisation of Universal's Tn Antigen biosensor as well as the development of other biosensors using the company's electrochemical platform technology.

Let's look closer at the announcement made by the biotech company this morning.

What was announced?

The Universal Biosensors share price is having a stellar day after the company announced new agreements between it and Deakin University's Institute of Frontier Metals (DIFM) and Swinburne University of Technology.

Through the deals, Universal Biosensors aims to create a portable device that can sense and monitor cancer from a finger prick of blood.

The two universities have been working on the company's electrochemical biosensors and the Tn Antigen cancer biomarker for more than 5 years.

The agreement with DIFM will contract half of DIFM's Senior Fellow Dr Wren Green's time and resources.

The deal with Swinburne will contract 80% of Dr Saimon Moraes Silva's time. Dr Silva will be under the supervision of Swinburne's School Software and Electrical Engineering and Iverson Health Innovation Research Institute's Professor Simon Moulton.

Combined, the universities should charge the company no more than $300,000, according to the company's release.

Commentary from management

Universal Biosensor's CEO John Sharman commented on the agreements, saying:

The knowledge and resources of DIFM and Swinburne will help deliver [a portable device capable of identifying, staging and monitoring cancer] as well as fast track the development of other biosensors we are working on.

Universal Biosensors share price snapshot

The Universal Biosensors share price is having a good year so far on the ASX, with today's news just the latest boost.

It's currently up by nearly 45% year to date. It's also up a whopping 278% over the last 12 months.

The company has a market capitalisation of around $110 million, with approximately 177 million shares outstanding.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL shares among most expensive on ASX. Is now a good time to buy?

Analysts predict CSL share price growth will keep on coming.

Read more »

A man looking at his laptop and thinking.
Healthcare Shares

Should you buy the dip in the ResMed share price?

Let's see what one leading broker is saying following yesterday's pullback.

Read more »

A woman puts up her hands and looks confused while sitting at her computer.
Healthcare Shares

Down 5%: What's going on with the ResMed share price?

Let's see what has spooked investors today and caused them to push the sell button.

Read more »

Beautiful young woman drinking fresh orange juice in kitchen.
Healthcare Shares

Guess which ASX 300 stock is jumping 11% on big news

This stock is having a day to remember on Thursday. But why?

Read more »

A group of medical researchers stands side by side with each other wearing white coats in their research laboratory with scientific equipment in the background.
Healthcare Shares

Trump executive order to hit these 3 ASX pharmaceutical stocks

Donald Trump’s new executive order caused these 3 ASX pharmaceutical stocks to crash on Monday.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Healthcare Shares

Guess which ASX 200 stock is jumping 16% on big news

Let's find out what news is getting investors excited this afternoon.

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Healthcare Shares

Why is this ASX 300 stock crashing 18% today?

Investors are rushing to the exits. But why? Let's look into things.

Read more »

Health professional working on his laptop.
Healthcare Shares

Are CSL shares at risk from the Trump tariffs?

How exposed are CSL shares to potential Trump medicinal tariffs?

Read more »